Checked
Erlotinib
Erlotinib is a kinase inhibitor (prescription), made by 6 manufacturers.
- Type
- Prescription
- Drug class
- Kinase Inhibitor
- Route
- Oral
- Manufacturers
- 6
Drug facts
- Name
- Erlotinib
- Active ingredients
- Erlotinib, Erlotinib Hydrochloride
- Drug class
- Kinase Inhibitor
- How it works
- Protein Kinase Inhibitors
- Dosage forms
- Tablet, Tablet, film coated
- Label holder
- Zydus Lifesciences Limited
- FDA application
- ANDA213065
- Label updated
- 11/28/2024
The FDA label text for this product is not available yet. See the full label on DailyMed using the link below.
Forms and strengths
From the FDA NDC Directory · 15 product codes
| Dosage form | Strength | Route | NDCs |
|---|---|---|---|
| Tablet | 25 mg | oral | 1 |
| Tablet | 100 mg | oral | 1 |
| Tablet | 150 mg | oral | 1 |
| Tablet, film coated | 25 mg | oral | 4 |
| Tablet, film coated | 100 mg | oral | 4 |
| Tablet, film coated | 150 mg | oral | 4 |
Side effect reports to FDA
FDA Adverse Event Reporting System (FAERS), 9,631 reports that list erlotinib, data through 07/30/2026
Anyone can report a problem to FDA, and a report does not mean the drug caused the problem. Reports can be duplicated or incomplete, and counts depend on how widely a drug is used. Do not stop or change a medicine because of this list. Talk to your doctor or pharmacist.
Most often reported reactions
- Death2,898
- Rash1,073
- Diarrhea1,012
- Off label use799
- Malignant neoplasm progression767
- Fatigue582
- Nausea541
- Drug resistance466
- Vomiting451
- Disease progression450
To report a side effect, use FDA MedWatch.
Manufacturers and labels
6 FDA labels
- Zydus Lifesciences LimitedShown hereANDA213065 · Label 11/28/2024 · NDC 70771-1521, 70771-1522, 70771-1523Full label
- Aurobindo Pharma LimitedANDA216342 · Label 06/06/2022 · NDC 59651-530, 59651-531, 59651-532Full label
- Camber Pharmaceuticals, Inc.ANDA209267 · Label 06/26/2024 · NDC 31722-263, 31722-264, 31722-265Full label
- Sun Pharmaceutical Industries, Inc.ANDA210300 · Label 11/06/2019 · NDC 63304-095, 63304-096, 63304-135Full label
- Teva Pharmaceuticals USA, Inc.ANDA091059 · Label 03/17/2021 · NDC 0093-7662, 0093-7663, 0093-7664Full label
- Zydus Pharmaceuticals USA Inc.ANDA213065 · Label 10/05/2023 · NDC 68382-913, 68382-914, 68382-915Full label
Related recalls
FDA drug recalls that name this drug or its active ingredient
Erlotinib: common questions
- Is Erlotinib a prescription drug?
- Yes. Erlotinib is a prescription (Rx) drug.
- Who makes Erlotinib?
- 6 manufacturers list Erlotinib with the FDA, including Zydus Lifesciences Limited, Aurobindo Pharma Limited, Camber Pharmaceuticals, Inc.
Source: U.S. Food and Drug Administration, openFDA drug label (SPL) and NDC Directory · Last updated 11/28/2024 · Label text is shown as published by the manufacturer. Not medical advice